Cargando…
Targeting Complement C3a Receptor to Improve Outcome After Ischemic Brain Injury
Ischemic stroke is a major cause of disability. No efficient therapy is currently available, except for the removal of the occluding blood clot during the first hours after symptom onset. Loss of function after stroke is due to cell death in the infarcted tissue, cell dysfunction in the peri-infarct...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437837/ https://www.ncbi.nlm.nih.gov/pubmed/34379293 http://dx.doi.org/10.1007/s11064-021-03419-6 |